Cocrystal Pharma Inc (COCP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Sales | 0 | 0 | 4,734 | 4,912 | 3,510 |
| Cost of Goods | N/A | N/A | 2,828 | 2,882 | 2,065 |
| Gross Profit | N/A | N/A | 1,906 | 2,031 | 1,445 |
| Operating Expenses | 1,058 | -10,593 | 2,396 | 2,650 | 2,101 |
| Operating Income | -1,058 | -2,563 | 339 | 263 | -591 |
| Interest Expense | 0 | 261 | 483 | 1,015 | 3,473 |
| Other Income | 0 | -324 | 22 | 38 | 418 |
| Pre-tax Income | -1,058 | -3,148 | -123 | -714 | -3,646 |
| Net Income Continuous | -1,058 | -3,148 | -123 | -714 | -3,646 |
| Net Income Discontinuous | N/A | -357 | 24 | N/A | N/A |
| Net Income | $-1,058 | $-3,505 | $-99 | $-714 | $-3,646 |
| EPS Basic Total Ops | -0.24 | -0.72 | 0.00 | -0.12 | -0.72 |
| EPS Basic Continuous Ops | -0.22 | -0.52 | 0.00 | -0.15 | -0.78 |
| EPS Diluted Total Ops | -0.24 | -0.72 | 0.00 | -0.12 | -0.72 |
| EPS Diluted Continuous Ops | -0.22 | -0.52 | 0.00 | -0.15 | -0.78 |
| EBITDA(a) | $-998 | $10,386 | $478 | $389 | $-475 |